医学
心悸
无症状的
心室流出道梗阻
猝死
心源性猝死
肥厚性心肌病
心脏病学
胸痛
内科学
心肌病
心力衰竭
作者
Anjali Tiku Owens,Thomas P. Cappola
出处
期刊:JAMA
[American Medical Association]
日期:2017-04-04
被引量:1
标识
DOI:10.1001/jama.2017.2584
摘要
Hypertrophic cardiomyopathy, defined as unexplained left ventricular hypertrophy, has an estimated prevalence of at least 1 in 500 and is among the most common forms of inherited heart disease.1 The pathophysiology of hypertrophic cardiomyopathy is complex and involves the interplay between diastolic dysfunction, myocardial ischemia, systolic anterior motion of the mitral valve resulting in outflow tract obstruction, and arrhythmia.2 Clinical presentations are heterogeneous and range from asymptomatic to palpitations, dyspnea, exercise intolerance, chest pain, syncope, and sudden death. Although the absolute risk of cardiac mortality is less than 1% per year,3 hypertrophic cardiomyopathy remains a common cause of sudden cardiac death in the young, especially in competitive athletes.4,5 Since hypertrophic cardiomyopathy has autosomal dominant inheritance, relatives of affected individuals have substantial risk of disease. Clinical evaluation of family members and cascade screening with genetic testing can identify those affected, many of whom are asymptomatic. When properly treated, the majority of patients with hypertrophic cardiomyopathy will have a normal life span.3
科研通智能强力驱动
Strongly Powered by AbleSci AI